North America diagnostic ultrasound market accounted for more than $1.5 billion revenue in 2018 and is expected to grow exponentially over forecast timeframe as high adoption of unhealthy diet, hypertension and obesity has escalated prevalence of chronic diseases in the region.
Read MoreThis clinical trials-related webinar will provide background on heavy menstrual bleeding (HMB) and discuss HMB trials from the PI and patient perspectives
Read MoreGynTect, a molecular diagnostic test developed by oncgnostics, allows reliable diagnostics of cervical cancer and the corresponding precancerous stages. The test has been revised now, offering an extension of its application, as compared to the first version. This extended version of GynTect is now available for use in laboratories. Moreover, oncgnostics has launched a crowd-investing campaign that offers small investors the opportunity to participate in the success of the company.
Read MoreWomen & Infants Hospital of Rhode Island has been ranked 19th in Gynecology (up from 26th in 2010-11), the number one hospital in the Providence metro area, and top-performing in cancer in U.S. News & World Report's 2011-12 Best Hospitals rankings.
Read MoreThe International Federation of Gynecology and Obstetrics (FIGO) launched a major component in the fight to control cervical cancer on 8 October 2009, releasing its global guidance document and announcing a unique partnership with the International P
Read More